CBOE · US Equities - Dividend & Fundamental · USA
The companies inside TMFM trade 11% above what we estimate they are worth. We could give a verdict on 90% of the fund's weight: 33 holdings as reported to the SEC at 31 May 2026.
Where the money is: 13% in companies in the buy zone, 19% about fairly valued, 58% overvalued, 11% without a verdict.
The ten largest holdings, with our verdict on each:
Its expense ratio is 0.85% a year: on $10,000 held flat that is $850 over 10 years and $1,700 over 20.